Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205307 · ClinicalTrials.gov registry record · NA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A NA study, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- Terminated
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT02205307 is a NA study that was terminated before completion, run by Novadaq Technologies ULC, now a part of Stryker. The registered enrollment target is 347 participants.
The verdict
NCT02205307, a NA study, was terminated before completion, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- TERMINATED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical procedures performed according to standard surgical practice alone.
Interventions
- DEVICE PINPOINT
- DEVICE SPY Elite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02205307
The ClinicalTrials.gov registry entry for NCT02205307 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novadaq Technologies ULC, now a part of Stryker, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PINPOINT is the first listed.
NCT02205307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02205307 about?
NCT02205307 is a clinical study titled "A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection". This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical ...
What is the current status of trial NCT02205307?
This trial is currently terminated. It is a NA study. The enrollment target is 347 participants. The study started on 2015-01. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02205307?
The interventions under investigation include: PINPOINT (DEVICE), SPY Elite (DEVICE).
Who is sponsoring clinical trial NCT02205307?
This trial is sponsored by Novadaq Technologies ULC, now a part of Stryker, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.